Related Experiment Videos
Vasospasm and platelet deposition in human arteries: effects of topical methylene blue
M L Bentz1, R A Sheppeck, T Macpherson
1Division of Plastic and Reconstructive Surgery, University of Pittsburgh School of Medicine, Pa.
Abstract:
Vasodilation of small blood vessels is controlled in part by the endothelium-derived relaxing factor (EDRF), which also inhibits platelet adhesion. Methylene blue (MB), which is occasionally applied directly to blood vessels during microsurgery to provide orientation and prevent torsion, is an irreversible inhibitor of the effects of endothelium-derived relaxing factor and may thereby augment both vasospasm and platelet responses. We have investigated the effects of the extravascular adventitial application of methylene blue on platelet deposition to human placental arteries (HPA) in the presence and absence of surgically induced vasospasm. A trend toward increased platelet deposition to human placental arteries was seen in each group but did not reach significance. The degree of platelet deposition to control human placental arteries suggests that the effects of methylene blue on platelet deposition may be dwarfed by the effects of surgical trauma and ischemia.
Insights
Methylene blue (MB) applied to blood vessels may increase platelet deposition by inhibiting endothelium-derived relaxing factor (EDRF). However, surgical trauma effects overshadowed MB
Area of Science:
- Vascular biology
- Endothelial function
- Hemostasis
Background:
- Endothelium-derived relaxing factor (EDRF) regulates blood vessel dilation and inhibits platelet aggregation.
- Methylene blue (MB) irreversibly inhibits EDRF, potentially increasing vasospasm and platelet responses.
- MB is used in microsurgery for vessel orientation and torsion prevention.
Purpose of the Study:
- To investigate the impact of extravascular methylene blue application on platelet deposition.
- To assess these effects in human placental arteries (HPA) with and without surgically induced vasospasm.
Main Methods:
- Human placental arteries (HPA) were used to evaluate platelet deposition.
- Extravascular adventitial application of methylene blue was performed.
- Surgical induction of vasospasm was employed in some experimental groups.
Main Results:
- A trend towards increased platelet deposition was observed in MB-treated HPA groups.
- This trend did not reach statistical significance.
- Platelet deposition in control HPA indicated significant effects from surgical trauma and ischemia.
Conclusions:
- The study suggests that methylene blue's effect on platelet deposition may be minimal compared to surgical trauma.
- Further research may be needed to clarify MB's role in vascular procedures.
- The findings highlight the complex interplay of factors influencing platelet response in surgical settings.